---
title: "Neonatology"
order: 6
category: "Pediatrics"
---

# Neonatology

## Overview

Neonatology is the medical subspecialty focused on the care of newborn infants, particularly ill or premature babies requiring specialized medical attention. The neonatal period, defined as the first 28 days of life, represents a critical transition from intrauterine to extrauterine life and is a time of significant physiologic adaptation. Understanding normal newborn physiology, recognizing pathologic conditions, and providing appropriate supportive care are essential for optimizing outcomes during this vulnerable period.

**Key Concept**: The neonatal period requires specialized knowledge of transitional physiology, gestational age-specific conditions, and the unique responses of newborns to illness and interventions.

### Definitions
- **Neonate**: Infant from birth through 28 days of life
- **Term infant**: Born at 37-42 weeks gestation
- **Preterm infant**: Born <37 weeks gestation
- **Post-term infant**: Born >42 weeks gestation
- **Low birth weight (LBW)**: <2,500 g
- **Very low birth weight (VLBW)**: <1,500 g
- **Extremely low birth weight (ELBW)**: <1,000 g

### Epidemiology
- **Neonatal mortality**: 3.8 per 1,000 live births in US (2020)
- **Preterm birth rate**: 10-11% of live births
- **Leading causes of neonatal death**: Prematurity, congenital anomalies, complications of pregnancy/delivery
- **NICU admissions**: 10-15% of all births

## Delivery Room Management

### Preparation

#### Risk Assessment
- **Maternal factors**: Age, medical conditions, medications
- **Pregnancy complications**: Preeclampsia, gestational diabetes, infections
- **Fetal factors**: Growth restriction, multiple gestation, anomalies
- **Labor factors**: Preterm labor, fetal distress, meconium
- **Delivery factors**: C-section, instrumented delivery, breech

#### Equipment Check
- **Radiant warmer**: Preheated
- **Oxygen and suction**: Functioning, available
- **Bag-mask ventilation**: Appropriate sizes (term and preterm)
- **Intubation equipment**: Laryngoscope, endotracheal tubes (2.5, 3.0, 3.5, 4.0)
- **Medications**: Epinephrine 1:10,000, volume expanders
- **Monitoring**: Pulse oximetry, ECG leads

### Newborn Resuscitation (NRP)

#### Initial Steps (30 seconds)
- **Warmth**: Dry, place under radiant warmer
- **Position**: Supine or side-lying, neck slightly extended
- **Suction**: Mouth then nose (if needed, avoid deep suctioning)
- **Stimulate**: Dry, rub back

#### Assessment
- **Breathing**: Rate, effort, adequacy
- **Heart rate**: Most important indicator
- **Color/perfusion**: Central cyanosis, pallor

#### Decision Points

##### Vigorous Term Infant
- **Criteria**: Good tone, breathing/crying, heart rate >100
- **Management**: Routine care with mother (delayed cord clamping if appropriate)

##### Needs Intervention
- **Criteria**: Not breathing adequately or HR <100
- **Management**: Positive pressure ventilation (PPV)

#### Positive Pressure Ventilation
- **Indications**: Apnea, gasping, or HR <100 despite stimulation
- **Rate**: 40-60 breaths/minute
- **Pressure**: Initial 20-25 cm H2O, may need higher for first few breaths
- **Assessment**: HR improvement within 15 seconds
- **Duration**: Continue until spontaneous breathing with HR >100

#### Chest Compressions
- **Indications**: HR <60 despite adequate PPV for 30 seconds
- **Technique**: 2-thumb encircling hands or 2-finger technique
- **Depth**: 1/3 anterior-posterior diameter of chest
- **Rate**: 90 compressions : 30 breaths (3:1 ratio)
- **Coordination**: Compressions and ventilations coordinated

#### Medications

##### Epinephrine
- **Indication**: HR <60 despite adequate PPV and chest compressions
- **Dose**: 0.01-0.03 mg/kg (0.1-0.3 mL/kg of 1:10,000) IV
- **Route**: Umbilical venous catheter preferred; can give via ETT initially while obtaining IV access
- **Repeat**: Every 3-5 minutes if needed

##### Volume Expansion
- **Indication**: Suspected blood loss or hypovolemia
- **Fluid**: Normal saline or O-negative blood
- **Dose**: 10 mL/kg IV over 5-10 minutes
- **Repeat**: As needed based on response

#### Special Situations

##### Meconium-Stained Amniotic Fluid
- **Vigorous infant**: Routine care, no special interventions
- **Non-vigorous infant**: Intubation and suction if PPV needed (changed from routine intubation)

##### Preterm Infant (<32 weeks)
- **Avoid hypothermia**: Polyethylene wrap or bag, increase room temperature
- **Lower oxygen**: Start with 21-30% oxygen, titrate based on SpO2
- **Delayed cord clamping**: If appropriate (30-60 seconds)
- **Gentle ventilation**: Lower pressures to avoid lung injury
- **Surfactant**: Early administration if intubated

### APGAR Scoring

Scored at 1 and 5 minutes (continue every 5 minutes if <7)

| Sign | 0 | 1 | 2 |
|------|---|---|---|
| Appearance (color) | Blue/pale | Acrocyanosis | Completely pink |
| Pulse (heart rate) | Absent | <100 | >100 |
| Grimace (reflex) | No response | Grimace | Cry/cough |
| Activity (tone) | Limp | Some flexion | Active motion |
| Respiration | Absent | Slow/irregular | Good, crying |

**Interpretation**:
- **7-10**: Normal
- **4-6**: Moderately depressed
- **0-3**: Severely depressed

**Note**: APGAR is assessment tool, not used to guide resuscitation decisions

## Newborn Physical Examination

### General Assessment

#### Vital Signs
- **Heart rate**: 120-160 bpm (awake), 80-100 (sleeping)
- **Respiratory rate**: 30-60 breaths/minute
- **Blood pressure**: 60-90/30-60 mmHg (term)
- **Temperature**: 36.5-37.5°C (97.7-99.5°F)

#### Measurements
- **Weight**: 2,500-4,000 g (term)
- **Length**: 48-53 cm (term)
- **Head circumference**: 33-37 cm (term)
- **Chest circumference**: 30-33 cm (term)

### Head and Neck

#### Skull
- **Fontanelles**: Anterior (diamond, closes 12-18 months), posterior (triangular, closes 2-3 months)
- **Sutures**: Should be mobile, not fused
- **Molding**: Overlapping sutures from birth process (resolves)
- **Caput succedaneum**: Soft tissue swelling, crosses suture lines, resolves quickly
- **Cephalohematoma**: Subperiosteal hemorrhage, does not cross sutures, resolves over weeks

#### Face
- **Symmetry**: Facial nerve palsy if asymmetric crying
- **Eyes**: Red reflex (rule out cataracts, retinoblastoma)
- **Ears**: Position, shape, tags, pits (low-set with renal anomalies)
- **Nose**: Patency (choanal atresia if cyanosis with feeding)
- **Mouth**: Palate intact, tongue size, frenulum

#### Neck
- **Clavicles**: Palpate for fracture
- **Masses**: Thyroid, cystic hygroma, sternocleidomastoid tumor

### Chest and Cardiovascular

#### Chest
- **Shape**: Symmetric expansion
- **Breath sounds**: Clear, equal bilaterally
- **Retractions**: Abnormal if present
- **Breast tissue**: 1-2 cm in term infants

#### Cardiovascular
- **Heart sounds**: Regular rate and rhythm
- **Murmurs**: Majority are benign, transitional physiology
- **Pulses**: Brachial and femoral (femoral weaker suggests coarctation)
- **Perfusion**: Capillary refill <2 seconds

### Abdomen

#### Inspection
- **Shape**: Slightly protuberant
- **Umbilical cord**: 2 arteries, 1 vein (single artery associated with anomalies)

#### Palpation
- **Liver**: 1-2 cm below costal margin
- **Spleen**: Tip palpable
- **Kidneys**: May be palpable bilaterally
- **Masses**: Abnormal, require evaluation

### Genitourinary

#### Males
- **Testes**: Descended bilaterally (may be retractile)
- **Penis**: Meatus at tip, normal size
- **Hypospadias**: Ventral meatus, associated with chordee
- **Scrotum**: Pigmentation, rugae (increases with maturity)

#### Females
- **Labia**: Majora may not cover minora in preterm
- **Hymen**: Present, may have mucoid discharge or pseudomenses
- **Urethra**: Separate from vagina

### Extremities and Spine

#### Hips
- **Barlow maneuver**: Adduction with posterior pressure (dislocates unstable hip)
- **Ortolani maneuver**: Abduction with anterior pressure (reduces dislocated hip)
- **Asymmetry**: Thigh folds, leg length

#### Extremities
- **Digits**: Count fingers and toes, polydactyly, syndactyly
- **Range of motion**: Full ROM all joints
- **Clubfoot**: Talipes equinovarus
- **Palmar creases**: Single crease suggests chromosomal abnormality

#### Spine
- **Inspection**: Midline, no dimples or tufts (if present, may indicate neural tube defect)
- **Palpation**: No masses or defects

### Skin

#### Normal Findings
- **Vernix caseosa**: White, cheese-like covering (more in preterm)
- **Lanugo**: Fine hair (more in preterm)
- **Mongolian spots**: Blue-gray patches on sacrum, back (benign)
- **Erythema toxicum**: Blotchy red rash with white/yellow papules (benign, resolves)
- **Milia**: White papules on nose/face (blocked sebaceous glands)
- **Nevus simplex**: "Stork bite" or "angel kiss" (fades)

#### Abnormal Findings
- **Jaundice**: In first 24 hours or excessive
- **Pustules**: Possible infection
- **Port-wine stain**: Vascular malformation (Sturge-Weber if on face)
- **Café-au-lait spots**: >6 suggests neurofibromatosis
- **Petechiae**: Thrombocytopenia, infection

### Neurologic

#### Tone
- **Flexed posture**: Normal in term infant
- **Hypotonia**: Floppy, may indicate neurologic or genetic condition
- **Hypertonia**: Increased tone, may indicate CNS injury

#### Primitive Reflexes
- **Moro**: Startle response (arms extend, then flex)
- **Rooting**: Turns toward stimulus on cheek
- **Sucking**: Sucks on object in mouth
- **Grasp**: Palmar and plantar grasp
- **Stepping**: Walking motions when held upright
- **Tonic neck**: "Fencing position" when head turned

## Routine Newborn Care

### Prophylactic Medications

#### Vitamin K
- **Indication**: Prevent vitamin K deficiency bleeding (VKDB)
- **Dose**: 1 mg IM within 6 hours of birth
- **Rationale**: Newborns have low vitamin K stores

#### Eye Prophylaxis
- **Indication**: Prevent gonococcal and chlamydial conjunctivitis
- **Medication**: Erythromycin 0.5% ointment
- **Timing**: Within 1 hour of birth

#### Hepatitis B Vaccine
- **Dose**: 0.5 mL IM
- **Timing**: Before hospital discharge (ideally within 24 hours)
- **Maternal HBsAg positive**: Also give HBIG within 12 hours

### Newborn Screening

#### Metabolic Screening
- **Timing**: After 24 hours of life, before discharge
- **Conditions screened**: Varies by state (29-50+ conditions)
- **Common disorders**:
  - PKU, MSUD, galactosemia
  - Congenital hypothyroidism
  - Congenital adrenal hyperplasia
  - Sickle cell disease
  - Cystic fibrosis
  - MCAD deficiency
- **Follow-up**: Abnormal results require prompt follow-up

#### Hearing Screening
- **Timing**: Before hospital discharge
- **Methods**: OAE (otoacoustic emissions) or ABR (auditory brainstem response)
- **Refer if fail**: Repeat testing within 1 month

#### Pulse Oximetry (CCHD Screening)
- **Timing**: After 24 hours or before discharge
- **Criteria**: SpO2 ≥95% in right hand and either foot, <3% difference
- **Fail criteria**: <90% in either extremity, 90-94% in both on 3 measures, >3% difference
- **Follow-up**: Echocardiography if fails

### Feeding

#### Breastfeeding
- **Recommended**: Exclusive breastfeeding for first 6 months
- **Initiation**: Within 1 hour of birth
- **Frequency**: 8-12 times per 24 hours
- **Duration**: 10-15 minutes per breast
- **Supplements**: Vitamin D 400 IU daily starting first few days
- **Support**: Lactation consultation for all mothers

#### Formula Feeding
- **Standard formula**: Cow's milk-based
- **Specialized formulas**: Soy, hydrolyzed, elemental (specific indications)
- **Amount**: 60-90 mL every 3-4 hours initially, increase as grows
- **Preparation**: Follow manufacturer instructions, safe water

#### Assessment of Adequate Intake
- **Wet diapers**: 6-8 per day by day 5
- **Stools**: Yellow, seedy (breastfed), formed (formula-fed)
- **Weight**: Return to birth weight by 2 weeks
- **Satisfaction**: Appears content after feeds

### Circumcision

#### Considerations
- **Not medically necessary**: Parental choice
- **Benefits**: Reduced UTI risk, penile cancer risk (rare), HIV transmission
- **Risks**: Bleeding, infection, poor cosmetic outcome (rare)
- **Contraindications**: Hypospadias, epispadias, bleeding disorder, prematurity/illness
- **Analgesia**: Required (dorsal penile nerve block, ring block, or topical)

## Prematurity

### Classification
- **Late preterm**: 34 0/7 to 36 6/7 weeks (70-75% of preterm births)
- **Moderately preterm**: 32 0/7 to 33 6/7 weeks
- **Very preterm**: 28 0/7 to 31 6/7 weeks
- **Extremely preterm**: <28 0/7 weeks

### Complications of Prematurity

#### Respiratory Distress Syndrome (RDS)

##### Pathophysiology
- **Surfactant deficiency**: Immature type II pneumocytes
- **Decreased compliance**: Atelectasis, increased work of breathing
- **Risk increases**: With decreasing gestational age

##### Clinical Presentation
- **Onset**: Within first hours of life
- **Symptoms**: Tachypnea, retractions, grunting, nasal flaring
- **Hypoxemia**: Increased oxygen requirement
- **Progression**: Worsens over first 48-72 hours, then improves

##### Diagnosis
- **Clinical**: Preterm infant with respiratory distress
- **Chest x-ray**: Ground-glass appearance, air bronchograms
- **Blood gas**: Hypoxemia, respiratory acidosis

##### Management
- **Surfactant**: Intratracheal administration (early rescue or prophylactic)
- **Respiratory support**:
  - CPAP: First-line for many infants
  - Mechanical ventilation: If CPAP insufficient
  - High-frequency ventilation: For severe cases
- **Oxygen**: Target SpO2 90-95% (avoid hyperoxia)
- **Supportive care**: Fluids, nutrition, temperature regulation
- **Prevention**: Antenatal corticosteroids if preterm delivery anticipated

#### Bronchopulmonary Dysplasia (BPD)

##### Definition
- **Oxygen requirement**: At 36 weeks PMA or 28 days of life (depending on severity)
- **Chronic lung disease**: Of prematurity

##### Risk Factors
- **Extreme prematurity**: <28 weeks
- **Prolonged ventilation**: Barotrauma, volutrauma
- **Oxygen toxicity**: Free radical injury
- **Infection**: Pneumonia, sepsis
- **Genetics**: Susceptibility

##### Clinical Presentation
- **Persistent oxygen requirement**: Beyond expected for RDS
- **Feeding difficulties**: Increased work of breathing
- **Poor growth**: Increased caloric needs

##### Management
- **Gentle ventilation**: Minimize barotrauma
- **Adequate nutrition**: High-calorie feeds
- **Diuretics**: Furosemide for fluid management
- **Bronchodilators**: May help reactive airway component
- **Corticosteroids**: Controversial, for severe cases
- **Oxygen at discharge**: Many require home oxygen

#### Retinopathy of Prematurity (ROP)

##### Pathophysiology
- **Abnormal retinal vascularization**: Oxygen exposure, prematurity
- **Phases**: Vascular growth arrest, then abnormal proliferation

##### Risk Factors
- **Prematurity**: <32 weeks
- **Low birth weight**: <1,500 g
- **Oxygen exposure**: Fluctuating or high oxygen levels
- **Other**: IVH, sepsis, anemia

##### Screening
- **Indications**: <30 weeks GA or <1,500 g birth weight (and selected 30-32 week infants)
- **Timing**: First exam at 31 weeks PMA or 4 weeks chronologic age
- **Frequency**: Based on findings, every 1-2 weeks until mature

##### Classification
- **Zones**: 1 (posterior), 2 (mid), 3 (anterior)
- **Stages**: 1 (demarcation line), 2 (ridge), 3 (extraretinal fibrovascular proliferation), 4 (partial detachment), 5 (total detachment)
- **Plus disease**: Vascular dilation and tortuosity

##### Management
- **Observation**: Mild ROP often regresses
- **Treatment**: Laser photocoagulation or anti-VEGF for threshold disease
- **Follow-up**: Long-term ophthalmology care

#### Intraventricular Hemorrhage (IVH)

##### Pathophysiology
- **Germinal matrix fragility**: Fragile blood vessels in premature infants
- **Fluctuating cerebral blood flow**: Hypo/hypertension, hypoxia, hypercapnia
- **Peak incidence**: First 72 hours of life

##### Risk Factors
- **Extreme prematurity**: <28 weeks, <1,000 g
- **Respiratory distress**: RDS, pneumothorax
- **Coagulopathy**: Thrombocytopenia
- **Rapid fluid/blood volume changes**

##### Classification (Grading)
- **Grade I**: Germinal matrix hemorrhage only
- **Grade II**: IVH without ventricular dilation
- **Grade III**: IVH with ventricular dilation
- **Grade IV**: IVH with parenchymal hemorrhage

##### Diagnosis
- **Screening ultrasound**: All infants <32 weeks or <1,500 g
- **Timing**: Day 7-10 and again at term-equivalent age

##### Management
- **Supportive care**: Most hemorrhages
- **Monitor for hydrocephalus**: Serial head ultrasounds, head circumference
- **Neurosurgical intervention**: If progressive hydrocephalus (VP shunt or reservoir)
- **Developmental follow-up**: Higher grades associated with neurodevelopmental impairment

#### Necrotizing Enterocolitis (NEC)

##### Pathophysiology
- **Multifactorial**: Intestinal immaturity, ischemia, bacteria, formula feeding
- **Inflammation**: Bowel wall necrosis, perforation

##### Risk Factors
- **Prematurity**: Most important (inverse relationship)
- **Formula feeding**: Human milk protective
- **Hypoxia/ischemia**: Perinatal asphyxia, PDA, polycythemia
- **Rapid feeding advancement**

##### Clinical Presentation
- **Feeding intolerance**: Residuals, emesis, abdominal distension
- **Bloody stools**: Occult or gross
- **Systemic signs**: Apnea, lethargy, temperature instability
- **Shock**: In severe cases

##### Diagnosis
- **Abdominal x-ray**:
  - Pneumatosis intestinalis (pathognomonic)
  - Portal venous gas
  - Pneumoperitoneum (perforation)
- **Laboratory**: Thrombocytopenia, acidosis, elevated lactate

##### Management

###### Medical (Majority)
- **NPO**: Bowel rest, gastric decompression
- **IV fluids**: Resuscitation, maintenance
- **Antibiotics**: Broad-spectrum (ampicillin, gentamicin, metronidazole or clindamycin)
- **TPN**: Nutritional support during bowel rest
- **Duration**: 7-14 days of bowel rest and antibiotics

###### Surgical
- **Indications**: Pneumoperitoneum, clinical deterioration despite medical management
- **Procedures**: Peritoneal drain or laparotomy with resection

##### Outcomes
- **Mortality**: 20-30% overall
- **Strictures**: Long-term complication (10-20%)
- **Short bowel syndrome**: If extensive resection

#### Patent Ductus Arteriosus (PDA)

##### Pathophysiology
- **Failure of closure**: Ductus arteriosus remains patent beyond postnatal period
- **Left-to-right shunt**: Pulmonary overcirculation, systemic hypoperfusion
- **Hemodynamically significant**: Large shunt causing symptoms

##### Clinical Presentation
- **Murmur**: Continuous at left upper sternal border
- **Bounding pulses**: Wide pulse pressure
- **Respiratory worsening**: Increased ventilator/oxygen needs
- **Feeding difficulties**: Poor growth

##### Diagnosis
- **Echocardiography**: Visualize ductus, assess shunt direction and magnitude

##### Management
- **Conservative**: Many close spontaneously, observation appropriate if asymptomatic
- **Fluid restriction**: Minimize pulmonary edema
- **Diuretics**: Furosemide
- **Medical closure**: Indomethacin or ibuprofen (prostaglandin inhibitors)
  - Contraindications: Renal insufficiency, thrombocytopenia, bleeding, NEC
- **Surgical ligation**: If medical management fails or contraindicated

## Neonatal Jaundice

### Physiology
- **Normal**: Physiologic jaundice in most newborns
- **Bilirubin production**: Increased RBC turnover, shorter RBC lifespan
- **Conjugation**: Immature liver enzyme (UGT1A1)
- **Excretion**: Slow gut transit, bacterial deconjugation, enterohepatic circulation

### Classification

#### Physiologic Jaundice
- **Onset**: Day 2-3 of life
- **Peak**: Day 3-5
- **Resolution**: 1-2 weeks (term), up to 3 weeks (preterm)
- **Level**: Usually <12 mg/dL (term)

#### Pathologic Jaundice (Red Flags)
- **Onset <24 hours**: Always pathologic
- **Total bilirubin >95th percentile**: For age in hours
- **Rising >0.2 mg/dL/hour** or >5 mg/dL/day
- **Direct bilirubin >2 mg/dL**: Or >20% of total
- **Clinical jaundice >2 weeks**: Requires evaluation

### Etiology of Pathologic Jaundice

#### Increased Production
- **Hemolytic disease**: ABO/Rh incompatibility, G6PD deficiency, hereditary spherocytosis
- **Polycythemia**: Delayed cord clamping, twin-twin transfusion
- **Bruising/cephalohematoma**: Reabsorption of blood
- **Sepsis**: Hemolysis

#### Decreased Conjugation
- **Crigler-Najjar syndrome**: Severe UGT1A1 deficiency
- **Gilbert syndrome**: Mild UGT1A1 deficiency
- **Hypothyroidism**: Decreased metabolism
- **Breastfeeding jaundice**: Inadequate intake, dehydration

#### Increased Enterohepatic Circulation
- **Breast milk jaundice**: Substances in breast milk inhibit conjugation
- **Intestinal obstruction**: Pyloric stenosis, ileus

#### Impaired Excretion (Cholestasis)
- **Biliary atresia**: Progressive obliteration of bile ducts
- **Neonatal hepatitis**: Viral, metabolic
- **Choledochal cyst**: Bile duct malformation
- **Alagille syndrome**: Bile duct paucity

### Assessment

#### History
- **Maternal blood type**: ABO and Rh
- **Ethnicity**: Asian, Mediterranean (G6PD deficiency)
- **Feeding**: Breastfeeding, adequacy of intake
- **Siblings**: Previous jaundice requiring treatment
- **Delivery**: Trauma, vacuum/forceps

#### Physical Examination
- **Extent**: Cephalocaudal progression (less reliable than measured bilirubin)
- **Hepatosplenomegaly**: Hemolysis, infection, storage disease
- **Pallor**: Anemia from hemolysis
- **Petechiae**: Thrombocytopenia, infection

#### Laboratory Studies
- **Total and direct bilirubin**: Essential for all jaundiced infants
- **Blood type and Coombs**: If mother O or Rh negative
- **CBC and smear**: Hematocrit, reticulocyte count, RBC morphology
- **G6PD**: If risk factors or unexplained hemolysis
- **Additional**: Based on clinical scenario (sepsis workup, thyroid, metabolic)

### Management

#### Phototherapy
- **Mechanism**: Converts unconjugated bilirubin to water-soluble isomers
- **Indications**: Based on nomogram (age in hours, risk factors)
- **Intensive phototherapy**: High irradiance, maximum skin exposure
- **Monitoring**: Bilirubin every 12-24 hours until declining
- **Side effects**: Loose stools, bronze baby syndrome (with cholestasis)

#### Exchange Transfusion
- **Indication**: Bilirubin at exchange level or rising despite phototherapy
- **Procedure**: Remove and replace blood volume
- **Purpose**: Rapidly decrease bilirubin, remove antibodies (if hemolysis)
- **Risks**: Infection, thrombosis, electrolyte abnormalities, death

#### Feeding
- **Encourage feeding**: 8-12 times per day
- **Supplementation**: If weight loss excessive or bilirubin rising despite feeding

#### Follow-Up
- **Early discharge (<48 hours)**: Follow-up within 1-2 days
- **Phototherapy**: Daily bilirubin until declining
- **Cholestasis**: Prompt referral to pediatric gastroenterology

### Complications

#### Acute Bilirubin Encephalopathy
- **Early**: Lethargy, hypotonia, poor feeding
- **Intermediate**: Moderate stupor, irritability, hypertonia
- **Advanced**: Opisthotonus, shrill cry, seizures, coma

#### Kernicterus (Chronic Bilirubin Encephalopathy)
- **Permanent damage**: Basal ganglia, brainstem nuclei
- **Manifestations**: Choreoathetoid cerebral palsy, sensorineural hearing loss, upward gaze palsy, dental enamel dysplasia
- **Prevention**: Prevent severe hyperbilirubinemia through screening and treatment

## Neonatal Infections

### Risk Factors for Sepsis
- **Maternal**: GBS colonization, chorioamnionitis, prolonged rupture of membranes (>18 hours), maternal fever
- **Delivery**: Preterm birth
- **Infant**: Low birth weight, male gender

### Early-Onset Sepsis (EOS)

#### Definition
- **Timing**: Within first 72 hours of life (usually <24 hours)
- **Source**: Vertical transmission from mother

#### Common Organisms
- **Group B Streptococcus (GBS)**: Most common (prevention through maternal screening and IAP)
- **E. coli**: Especially in VLBW infants
- **Other**: Listeria, enterococcus, other gram-negatives

#### Clinical Presentation
- **Respiratory distress**: Most common presentation
- **Temperature instability**: Fever or hypothermia
- **Poor feeding**: Lethargy
- **Tachycardia or bradycardia**
- **Hypotension**: Shock

#### Evaluation
- **Blood culture**: Gold standard
- **CBC with differential**: I:T ratio, absolute neutrophil count
- **CRP**: Not useful initially, may help with duration decisions
- **Lumbar puncture**: If clinically septic or positive blood culture
- **Chest x-ray**: If respiratory symptoms

#### Management
- **Empiric antibiotics**: Ampicillin + gentamicin
- **Duration**: 48 hours if negative cultures and low suspicion; 7-14 days if positive (21 days for meningitis)
- **Supportive care**: Fluids, vasopressors, ventilation as needed

### Late-Onset Sepsis (LOS)

#### Definition
- **Timing**: After 72 hours of life
- **Source**: Nosocomial (NICU) or community-acquired

#### Common Organisms
- **Coagulase-negative Staph**: Most common in NICU (associated with central lines)
- **S. aureus**: Including MRSA
- **Gram-negatives**: E. coli, Klebsiella, Pseudomonas
- **Candida**: In extremely premature or immunocompromised

#### Clinical Presentation
- **Subtle signs**: Feeding intolerance, temperature instability
- **Respiratory**: Apnea, increased support needs
- **Cardiovascular**: Tachycardia, poor perfusion
- **Central line associated**: Erythema, induration at site

#### Evaluation and Management
- **Similar to EOS**: Blood culture, CBC, CRP
- **Antibiotics**: Vancomycin + gentamicin (or third-generation cephalosporin)
- **Line removal**: Consider for coagulase-negative staph bacteremia
- **Antifungal**: Add if risk factors for Candida

### TORCH Infections

#### Toxoplasmosis
- **Transmission**: Maternal primary infection during pregnancy
- **Clinical**: Often asymptomatic at birth; chorioretinitis, intracranial calcifications, hydrocephalus
- **Diagnosis**: Serology, PCR
- **Treatment**: Pyrimethamine, sulfadiazine, folinic acid

#### Other (Syphilis, VZV, Parvovirus)
- **Congenital syphilis**: Hepatosplenomegaly, rash, osteochondritis, snuffles
- **VZV**: Congenital varicella syndrome if maternal infection in first trimester
- **Parvovirus B19**: Hydrops fetalis, severe anemia

#### Rubella
- **Congenital rubella syndrome**: Cataracts, deafness, cardiac defects (PDA, PPS)
- **Other**: Microcephaly, intellectual disability, growth restriction
- **Prevention**: Maternal immunization before pregnancy

#### Cytomegalovirus (CMV)
- **Most common congenital infection**: 0.5-1% of all births
- **Transmission**: Primary or reactivation during pregnancy
- **Clinical**: Majority asymptomatic; IUGR, hepatosplenomegaly, petechiae, jaundice, microcephaly, periventricular calcifications
- **Diagnosis**: Urine or saliva PCR within first 3 weeks of life
- **Treatment**: Valganciclovir for symptomatic disease (6 months)
- **Prognosis**: Sensorineural hearing loss (may be progressive)

#### Herpes Simplex Virus (HSV)
- **Transmission**: Intrapartum (most common), in utero, postnatal
- **Clinical presentations**:
  - Skin, eye, mouth (SEM): Best prognosis
  - CNS disease: Seizures, lethargy
  - Disseminated: Multi-organ involvement, high mortality
- **Diagnosis**: Surface cultures, CSF PCR, blood PCR
- **Treatment**: High-dose IV acyclovir (14-21 days), then oral suppression
- **Prevention**: C-section if active maternal lesions at delivery

## Hypoxic-Ischemic Encephalopathy (HIE)

### Pathophysiology
- **Perinatal asphyxia**: Hypoxia and decreased perfusion
- **Brain injury**: Neuronal death, edema

### Clinical Presentation

#### Sarnat Staging
- **Stage 1 (Mild)**: Hyperalert, normal tone, intact primitive reflexes
- **Stage 2 (Moderate)**: Lethargic, hypotonia, depressed reflexes, seizures
- **Stage 3 (Severe)**: Stuporous/comatose, flaccid, absent reflexes, decerebrate posturing

#### Associated Findings
- **Multi-organ dysfunction**: Renal, cardiac, hepatic, hematologic
- **Seizures**: Common in moderate-severe
- **Feeding difficulties**: Poor suck, unable to protect airway

### Diagnosis
- **Clinical**: History of sentinel event, low APGAR scores, encephalopathy
- **Laboratory**: Metabolic acidosis (pH <7.0, base deficit ≥12)
- **EEG**: Background abnormalities, seizures
- **Imaging**: MRI showing characteristic patterns (basal ganglia, watershed)

### Management

#### Therapeutic Hypothermia
- **Criteria**: ≥36 weeks gestation, evidence of perinatal hypoxia/ischemia, moderate-severe encephalopathy
- **Timing**: Must start within 6 hours of birth
- **Method**: Whole body or selective head cooling to 33-34°C
- **Duration**: 72 hours, then slow rewarming
- **Benefit**: Reduces death and disability in moderate-severe HIE

#### Supportive Care
- **Ventilation**: As needed for respiratory failure
- **Hemodynamics**: Maintain normal blood pressure
- **Fluids**: Restrict to 40-60 mL/kg/day initially (SIADH common)
- **Seizure management**: Treat clinical seizures; phenobarbital first-line
- **Avoid hyperthermia**: Strict temperature control
- **Glucose**: Maintain normoglycemia

### Prognosis
- **Mild HIE**: Usually normal outcome
- **Moderate HIE**: 30-40% neurodevelopmental impairment (reduced with hypothermia)
- **Severe HIE**: High mortality and morbidity
- **MRI**: Helpful for prognostication (timing: 7-10 days)

## Key Points

- APGAR score is an assessment tool, not a guide for resuscitation; resuscitation decisions based on airway, breathing, heart rate
- Most important indicator of adequate newborn resuscitation is rising heart rate
- Routine newborn care includes vitamin K, eye prophylaxis, hepatitis B vaccine, and screening (metabolic, hearing, pulse oximetry)
- Prematurity complications are inversely proportional to gestational age: RDS, BPD, IVH, ROP, NEC
- Surfactant administration and antenatal steroids dramatically improve outcomes in RDS
- Jaundice in the first 24 hours is always pathologic and requires immediate evaluation
- Phototherapy indications based on hour-specific nomograms considering gestational age and risk factors
- Early-onset sepsis is usually from vertical transmission (GBS, E. coli); empiric treatment is ampicillin + gentamicin
- Late-onset sepsis is usually nosocomial; coagulase-negative staph most common in NICU
- Therapeutic hypothermia must be initiated within 6 hours of birth for moderate-severe HIE
- Breastfeeding is protective against NEC; human milk should be encouraged for all premature infants
- Developmental follow-up is essential for high-risk neonates (extreme prematurity, severe HIE, grade III-IV IVH)

## References

1. American Academy of Pediatrics, American Heart Association. Textbook of Neonatal Resuscitation, 8th Edition. Elk Grove Village, IL: American Academy of Pediatrics; 2021.
2. Benitz WE, Committee on Fetus and Newborn. Management of Neonates With Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics. 2019;144(2):e20191881.
3. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2004;114(1):297-316.
4. Papile LA, Baley JE, Benitz W, et al. Hypothermia and Neonatal Encephalopathy. Pediatrics. 2014;133(6):1146-1150.
5. Jensen EA, Schmidt B. Epidemiology of Bronchopulmonary Dysplasia. Birth Defects Res A Clin Mol Teratol. 2014;100(3):145-157.
